GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (FRA:PIG) » Definitions » Cyclically Adjusted PS Ratio

Perrigo Co (FRA:PIG) Cyclically Adjusted PS Ratio : 0.75 (As of May. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Perrigo Co Cyclically Adjusted PS Ratio?

As of today (2024-05-27), Perrigo Co's current share price is €25.87. Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €34.62. Perrigo Co's Cyclically Adjusted PS Ratio for today is 0.75.

The historical rank and industry rank for Perrigo Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:PIG' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.69   Med: 1.87   Max: 7.64
Current: 0.74

During the past years, Perrigo Co's highest Cyclically Adjusted PS Ratio was 7.64. The lowest was 0.69. And the median was 1.87.

FRA:PIG's Cyclically Adjusted PS Ratio is ranked better than
79.27% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.11 vs FRA:PIG: 0.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Perrigo Co's adjusted revenue per share data for the three months ended in Mar. 2024 was €7.235. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €34.62 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted PS Ratio Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.33 1.10 0.91 0.85

Perrigo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 0.89 0.83 0.85 0.85

Competitive Comparison of Perrigo Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted PS Ratio falls into.



Perrigo Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Perrigo Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=25.87/34.62
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Perrigo Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.235/120.9901*120.9901
=7.235

Current CPI (Mar. 2024) = 120.9901.

Perrigo Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 5.471 100.773 6.569
201409 5.494 100.474 6.616
201412 6.353 99.576 7.719
201503 6.885 99.975 8.332
201506 7.014 100.573 8.438
201509 8.156 100.274 9.841
201512 9.017 99.676 10.945
201603 8.674 99.676 10.529
201606 8.331 101.072 9.973
201609 7.844 100.274 9.465
201612 8.789 99.676 10.668
201703 7.774 100.374 9.371
201706 7.688 100.673 9.240
201709 7.290 100.474 8.779
201712 7.635 100.075 9.231
201803 6.980 100.573 8.397
201806 7.322 101.072 8.765
201809 7.067 101.371 8.435
201812 7.714 100.773 9.262
201903 7.632 101.670 9.082
201906 7.450 102.168 8.822
201909 7.906 102.268 9.353
201912 2.338 102.068 2.771
202003 7.140 102.367 8.439
202006 6.128 101.769 7.285
202009 6.189 101.072 7.409
202012 6.352 101.072 7.604
202103 6.303 102.367 7.450
202106 6.095 103.364 7.134
202109 6.624 104.859 7.643
202112 7.303 106.653 8.285
202203 7.281 109.245 8.064
202206 7.884 112.779 8.458
202209 8.256 113.504 8.801
202212 8.091 115.436 8.480
202303 8.182 117.609 8.417
202306 8.062 119.662 8.151
202309 7.692 120.749 7.707
202312 7.824 120.749 7.840
202403 7.235 120.990 7.235

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (FRA:PIG) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Perrigo Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (FRA:PIG) Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (FRA:PIG) Headlines

No Headlines